Literature DB >> 25829072

Physiological roles of miR-155.

Ryuichi Mashima1.   

Abstract

miR-155 is involved in non-coding microRNAs found in humans, mice and chickens of which the sequence is conserved. Historically, miR-155 was identified as a B-cell integration cluster (bic), which induces B-cell leucosis in chickens, by its activation through viral promoter insertion. Subsequent studies have shown that transgenic mice expressing miR-155 in B cells generated lymphoma, showing that miR-155 is oncogenic. Biochemical investigation identifies many substrates of miR-155, and one of them in B cells and macrophages is the SH2-domain containing inositol-5'-phosphatase 1. A deficiency of miR-155 in the immune system causes attenuated immune functions. Clinically, several types of malignancy including diffuse large B-cell lymphoma have high miR-155 expression levels.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  SH2-domain containing inositol-5′-phosphatase 1; inflammation; microRNA; signal transduction; tyrosine kinase

Mesh:

Substances:

Year:  2015        PMID: 25829072      PMCID: PMC4479532          DOI: 10.1111/imm.12468

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  69 in total

1.  Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA.

Authors:  W Tam
Journal:  Gene       Date:  2001-08-22       Impact factor: 3.688

2.  Identification of MyD88 as a novel target of miR-155, involved in negative regulation of Helicobacter pylori-induced inflammation.

Authors:  Bin Tang; Bin Xiao; Zhen Liu; Na Li; En-Dong Zhu; Bo-Sheng Li; Qing-Hua Xie; Yuan Zhuang; Quan-Ming Zou; Xu-Hu Mao
Journal:  FEBS Lett       Date:  2010-02-26       Impact factor: 4.124

3.  Identification of tissue-specific microRNAs from mouse.

Authors:  Mariana Lagos-Quintana; Reinhard Rauhut; Abdullah Yalcin; Jutta Meyer; Winfried Lendeckel; Thomas Tuschl
Journal:  Curr Biol       Date:  2002-04-30       Impact factor: 10.834

4.  Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis.

Authors:  Deepak Rai; Sang-Woo Kim; Morgan R McKeller; Patricia L M Dahia; Ricardo C T Aguiar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

Review 5.  Immunity to systemic Salmonella infections.

Authors:  Pietro Mastroeni
Journal:  Curr Mol Med       Date:  2002-06       Impact factor: 2.222

6.  Comparative analysis of mononuclear cell surface markers in atopic processes--a preliminary study.

Authors:  Yonathan Garfias; Enrique Rojas-Ramos; María del Carmen Jiménez; Salvador Martínez-Cairo; Raúl Chávez; Patricia Gorocica; Edgar Zenteno; Ricardo Lascurain
Journal:  Immunol Invest       Date:  2003-02       Impact factor: 3.657

7.  Inositol phosphatase SHIP1 is a primary target of miR-155.

Authors:  Ryan M O'Connell; Aadel A Chaudhuri; Dinesh S Rao; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-09       Impact factor: 11.205

8.  Regulation of the germinal center response by microRNA-155.

Authors:  To-Ha Thai; Dinis Pedro Calado; Stefano Casola; K Mark Ansel; Changchun Xiao; Yingzi Xue; Andrew Murphy; David Frendewey; David Valenzuela; Jeffery L Kutok; Marc Schmidt-Supprian; Nikolaus Rajewsky; George Yancopoulos; Anjana Rao; Klaus Rajewsky
Journal:  Science       Date:  2007-04-27       Impact factor: 47.728

9.  Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice.

Authors:  Stefan Costinean; Sukhinder K Sandhu; Irene M Pedersen; Esmerina Tili; Rossana Trotta; Danilo Perrotti; David Ciarlariello; Paolo Neviani; Jason Harb; Lauren Rachel Kauffman; Aaditya Shidham; Carlo Maria Croce
Journal:  Blood       Date:  2009-06-11       Impact factor: 22.113

10.  Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas.

Authors:  Irene M Pedersen; Dennis Otero; Elaine Kao; Ana V Miletic; Christoffer Hother; Elisabeth Ralfkiaer; Robert C Rickert; Kirsten Gronbaek; Michael David
Journal:  EMBO Mol Med       Date:  2009-08       Impact factor: 12.137

View more
  65 in total

Review 1.  Role of miRNAs in immune responses and immunotherapy in cancer.

Authors:  Maria Angelica Cortez; Simone Anfossi; Rishab Ramapriyan; Hari Menon; Semra Cemre Atalar; Maureen Aliru; James Welsh; George A Calin
Journal:  Genes Chromosomes Cancer       Date:  2019-04       Impact factor: 5.006

Review 2.  MicroRNA-155: A Master Regulator of Inflammation.

Authors:  Guruswamy Mahesh; Roopa Biswas
Journal:  J Interferon Cytokine Res       Date:  2019-03-20       Impact factor: 2.607

3.  New players in chronic lung disease identified at the European Respiratory Society International Congress in Paris 2018: from microRNAs to extracellular vesicles.

Authors:  Olivier Burgy; Elena Fernandez Fernandez; Sara Rolandsson Enes; Melanie Königshoff; Catherine M Greene; Sabine Bartel
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Expression of microRNA-155 in inflammatory cells modulates liver injury.

Authors:  Delia Blaya; Beatriz Aguilar-Bravo; Fengjie Hao; Silvia Casacuberta-Serra; Mar Coll; Luis Perea; Júlia Vallverdú; Isabel Graupera; Elisa Pose; Laura Llovet; Jordi Barquinero; Francisco Javier Cubero; Juan Caballería; Pere Ginès; Pau Sancho-Bru
Journal:  Hepatology       Date:  2018-05-02       Impact factor: 17.425

5.  Behavior of two Leishmania infantum strains-evaluation of susceptibility to antimonials and expression of microRNAs in experimentally infected J774 macrophages and in BALB/c mice.

Authors:  Stella Costa Silva; Débora Faria Silva; Tamires Cunha Almeida; Fernanda Barçante Perasoli; André Talvani Pedrosa da Silva; Glenda Nicioli da Silva; Simone Aparecida Rezende
Journal:  Parasitol Res       Date:  2018-06-25       Impact factor: 2.289

Review 6.  Functional RNAs control T follicular helper cells.

Authors:  Shingo Ichimiya; Ryuta Kamekura; Koji Kawata; Motonari Kamei; Tetsuo Himi
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

7.  TREM-1-accentuated lung injury via miR-155 is inhibited by LP17 nanomedicine.

Authors:  Zhihong Yuan; Mansoor Syed; Dipti Panchal; Myungsoo Joo; Chetna Bedi; Sokbee Lim; Hayat Onyuksel; Israel Rubinstein; Marco Colonna; Ruxana T Sadikot
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-12-18       Impact factor: 5.464

8.  MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report.

Authors:  Antonella Caivano; Francesco La Rocca; Vittorio Simeon; Marco Girasole; Simone Dinarelli; Ilaria Laurenzana; Angelo De Stradis; Luciana De Luca; Stefania Trino; Antonio Traficante; Giovanni D'Arena; Giovanna Mansueto; Oreste Villani; Giuseppe Pietrantuono; Luca Laurenti; Luigi Del Vecchio; Pellegrino Musto
Journal:  Cell Oncol (Dordr)       Date:  2016-10-19       Impact factor: 6.730

Review 9.  The role of microRNAs in the healing of diabetic ulcers.

Authors:  Golnaz Goodarzi; Mahmood Maniati; Durdi Qujeq
Journal:  Int Wound J       Date:  2019-02-28       Impact factor: 3.315

10.  Survival of autoreactive T lymphocytes by microRNA-mediated regulation of apoptosis through TRAIL and Fas in type 1 diabetes.

Authors:  V M de Jong; A R van der Slik; S Laban; R van 't Slot; B P C Koeleman; A Zaldumbide; B O Roep
Journal:  Genes Immun       Date:  2016-07-28       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.